Genetic susceptibility, biomarker respones, and cancer

Mutation Research - Reviews in Mutation Research

Volumn 544, Issue 2-3, 2003, Pages 339-348

  Norppa, Hannu ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Biomarker; DNA; Genotoxic carcinogen; Polymorphisms

Indexed keywords

1,3 BUTADIENE; BIOLOGICAL MARKER; GLUTATHIONE TRANSFERASE; STYRENE; TOBACCO SMOKE;

CANCER; CLINICAL TRIAL; CONFERENCE PAPER; DNA ADDUCT; DNA DAMAGE; DNA REPAIR; ETHNOLOGY; EXPOSURE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTOXICITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; META ANALYSIS; MOLECULAR INTERACTION; PRIORITY JOURNAL; SMOKING;

NICOTIANA TABACUM;

EID: 0345686440     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2003.09.006     Document Type: Conference Paper

References (87)

1. Shields P.G., Harris C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J. Clin. Oncol. 18:2000;2309-2315.
2. Hirvonen A. Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer. Environ. Health Perspect. 107(Suppl. 1):1999;37-47.
3. R.C. Strange, A.A. Fryer, The glutathione S-transferases: influence of polymorphism on cancer susceptibility, IARC Sci. Publ. 148 (1999) 231-249.
4. Wormhoudt L.W., Commandeur J.N., Vermeulen N.P. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit. Rev. Toxicol. 29:1999;59-124.
5. Au W.W., Oh H.Y., Grady J., Salama S.A., Heo M.Y. Usefulness of genetic susceptibility and biomarkers for evaluation of environmental health risk. Environ. Mol. Mutagen. 37:2001;215-225.
6. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., Baranova H., Bathum L., Benhamou S., Boffetta P., Bouchardy C., Breskvar K., Brockmöller J., Cascorbi I., Clapper M.L., Coutelle C., Daly A., Dell'Omo M., Dolzan V., Dresler C.M., Fryer A., Haugen A., Hein D.W., Hildesheim A., Hirvonen A., Hsieh L.L., Ingelman-Sundberg M., Kalina I., Kang D., Kihara M., Kiyohara C., Kremers P., Lazarus P., Le Marchand L., Lechner M.C., van Lieshout E.M., London S., Manni J.J., Maugard C.M., Morita S., Nazar-Stewart V., Noda K., Oda Y., Parl F.F., Pastorelli R., Persson I., Peters W.H., Rannug A., Rebbeck T., Risch A., Roelandt L., Romkes M., Ryberg D., Salagovic J., Schoket B., Seidegard J., Shields P.G., Sim E., Sinnet D., Strange R.C., Stücker I., Sugimura H., To-Figueras J., Vineis P., Yu M.C., Taioli E. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomar. Prev. 10:2001;1239-1248.
7. Benhamou S., Lee W.J., Alexandrie A.K., Boffetta P., Bouchardy C., Butkiewicz D., Brockmöller J., Clapper M.L., Daly A., Dolzan V., Ford J., Gaspari L., Haugen A., Hirvonen A., Husgafvel-Pursiainen K., Ingelman-Sundberg M., Kalina I., Kihara M., Kremers P., Le Marchand L., London S.J., Nazar-Stewart V., Onon-Kihara M., Rannug A., Romkes M., Ryberg D., Seidegard J., Shields P., Strange R.C., Stücker I., To-Figueras J., Brennan P., Taioli E. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis. 23:2002;1343-1350.
8. Engel L.S., Taioli E., Pfeiffer R., Garcia-Closas M., Marcus P.M., Lan Q., Boffetta P., Vineis P., Autrup H., Bell D.A., Branch R.A., Brockmöller J., Daly A.K., Heckbert S.R., Kalina I., Kang D., Katoh T., Lafuente A., Lin H.J., Romkes M., Taylor J.A., Rothman N. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am. J. Epidemiol. 156:2002;95-109.
9. Norppa H. Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes. Environ. Health Perspect. 105(Suppl. 4):1997;829-835.
10. H. Norppa, A. Hirvonen, Metabolic polymorphisms of importance in biomonitoring, in: D. Anderson, A.E. Karakaya, R.J. Šrám (Eds.), Human Monitoring After Environmental and Occupational Exposure to Chemical and Physical Agents, IOS Press, Amsterdam, 2000, pp. 289-299.
11. H. Norppa, Influence of genetic enzyme polymorphisms on cytogenetic biomarkers, in: D. Anderson, A.E. Karakaya, R.J. Šrám (Eds.), Human Monitoring After Environmental and Occupational Exposure to Chemical and Physical Agents, IOS Press, Amsterdam, 2000, pp. 300-311.
12. Norppa H. Genetic polymorphisms and chromosome damage. Int. J. Hyg. Environ. Health. 204:2001;31-38.
13. H. Norppa, Cytogenetic biomarkers, IARC Sci. Publ. (2003) in press.
14. Au W.W., Sierra-Torres C.H., Cajas-Salazar N., Shipp B.K., Legator M.S. Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility. Environ. Health Perspect. 107:1999;501-505.
15. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res. 464:2000;65-76.
16. Knudsen L.E., Loft S.H., Autrup H. Risk assessment: the importance of genetic polymorphisms in man. Mutat. Res. 482:2001;83-88.
17. Pavanello S., Clonfero E. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutat. Res. 463:2000;285-308.
18. Hagmar L., Bonassi S., Strömberg U., Brøgger A., Knudsen L.E., Norppa H., Reuterwall C. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res. 58:1998;4117-4121.
19. Bonassi S., Hagmar L., Strömberg U., Montagud A.H., Tinnerberg H., Forni A., Heikkilä P., Wanders S., Wilhardt P., Hansteen I.-L., Knudsen L.E., Norppa H. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. Cancer Res. 60:2000;1619-1625.
20. Bonassi S., Au W.W. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat. Res. 511:2002;73-86.
21. Brockmöller J., Gross D., Kerb R., Drakoulis N., Roots I. Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class mu gene detected by polymerase chain reaction. Biochem. Pharmacol. 43:1992;647-650.
22. Strange R.C., Jones P.W., Fryer A.A. Glutathione S-transferase: genetics and role in toxicology. Toxicol. Lett. 112-113:2000;357-363.
23. Strange R.C., Spiteri M.A., Ramachandran S., Fryer A.A. Glutathione-S-transferase family of enzymes. Mutat. Res. 482:2001;21-26.
24. Salama S.A., Abdel-Rahman S.Z., Sierra-Torres C.H., Hamada F.A., Au W.W. Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity. Pharmacogenetics. 9:1999;735-743.
25. Salama S.A., Sierra-Torres C.H., Oh H.Y., Hamada F.A., Au W.W. Variant metabolizing gene alleles determine the genotoxicity of benzo[a]pyrene. Environ. Mol. Mutagen. 37:2001;17-26.
26. Brockmöller J., Kerb R., Drakoulis N., Staffeldt B., Roots I. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res. 54:1994;4103-4111.
27. McWilliams J.E., Sanderson B.J., Harris E.L., Richert-Boe K.E., Henner W.D. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 4:1995;589-594.
28. Houlston R.S. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 8:1999;675-682.
29. P. Vineis, A. d'Errico, N. Malats, P. Boffetta, Overall evaluation and research perspectives, in: P. Vineis, N. Malats, M. Lang, A. d'Errico, N. Caporaso, J. Cuzick, P. Boffetta (Eds.), Metabolic Polymorphisms and Susceptibility to Cancer, IARC, Lyon, 1999.
30. Vineis P. The relationship between polymorphisms of xenobiotic metabolizing enzymes and susceptibility to cancer. Toxicology. 181-182:2002;457-462.
31. Johns L.E., Houlston R.S. Glutathione S-transferase mu1 (GSTM1) status and bladder cancer risk: a meta-analysis. Mutagenesis. 15:2000;399-404.
32. Shields P.G., Bowman E.D., Harrington A.M., Doan V.T., Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res. 53:1993;3486-3492.
33. Ryberg D., Hewer A., Phillips D.H., Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res. 54:1994;5801-5803.
34. Ryberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Wolf C.R., Ogreid D., Ulvik A., Vu P., Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18:1997;1285-1289.
35. Butkiewicz D., Grzybowska E., Hemminki K., Øvrebø S., Haugen A., Motykiewicz G., Chora̧zy M. Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1 CYP2D6 and GSTM1 genetic polymorphisms. Mutat. Res. 415:1998;97-108.
36. Butkiewicz D., Cole K.J., Phillips D.H., Harris C.C., Chora̧zy M. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels. Eur. J. Cancer Prev. 8:1999;315-323.
37. Butkiewicz D., Grzybowska E., Phillips D.H., Hemminki K., Chora̧zy M. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells. Environ. Mol. Mutagen. 35:2000;99-105.
38. *0 genotypes. Pharmacogenetics. 8:1998;109-118.
39. Alexandrov K., Cascorbi I., Rojas M., Bouvier G., Kriek E., Bartsch H. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation. Carcinogenesis. 23:2002;1969-1977.
40. Scarpato R., Hirvonen A., Migliore L., Falck G., Norppa H. Influence of GSTM1 and GSTT1 polymorphisms on the frequency of chromosome aberrations in lymphocytes of smokers and pesticide-exposed greenhouse workers. Mutat. Res. 389:1997;227-235.
41. van Poppel G., Verhagen H., van't Veer P., van Bladeren P.J. Markers for cytogenetic damage in smokers: associations with plasma antioxidants and glutathione S-transferase mu. Cancer Epidemiol. Biomarkers Prev. 2:1993;441-447.
42. Cheng T.J., Hwang S.J., Kuo H.W., Luo J.C., Chang M.J. Exposure to epichlorohydrin and dimethylformamide, glutathione S-transferases and sister chromatid exchange frequencies in peripheral lymphocytes. Arch. Toxicol. 73:1999;282-287.
43. Wu F.Y., Tsai F.J., Kuo H.W., Tsai C.H., Wu W.Y., Wang R.Y., Lai J.S. Cytogenetic study of workers exposed to chromium compounds. Mutat. Res. 464:2000;289-296.
44. Cheng T.J., Christiani D.C., Xu X., Wain J.C., Wiencke J.K., Kelsey K.T. Glutathione S-transferase mu genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes. Cancer Epidemiol. Biomarkers Prev. 4:1995;535-542.
45. Cheng T.J., Christiani D.C., Wiencke J.K., Wain J.C., Xu X., Kelsey K.T. Comparison of sister chromatid exchange frequency in peripheral lymphocytes in lung cancer cases and controls. Mutat. Res. 348:1995;75-82.
46. Duell E.J., Wiencke J.K., Cheng T.J., Varkonyi A., Zuo Z.F., Ashok T.D., Mark E.J., Wain J.C., Christiani D.C., Kelsey K.T. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 21:2000;965-971.
47. Rollinson S., Roddam P., Kane E., Roman E., Cartwright R., Jack A., Morgan G.J. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis. 21:2000;43-47.
48. Arruda V.R., Lima C.S.P., Grignoli C.R.E., de Melo M.B., Lorand-Metze I., Alberto F.L., Saad S.T.O., Costa F.F. Increased risk for acute myeloid leukaemiain individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects. Eur. J. Haematol. 66:2001;383-388.
49. Wiencke J.K., Wrensch M.R., Miike R., Petrakis N.L. Individual susceptibility to induced chromosome damage and its implications for detecting genotoxic exposures in human populations. Cancer Res. 51:1991;5266-5269.
50. Wiencke J.K., Pemble S., Ketterer B., Kelsey K.T. Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol. Biomarkers Prev. 4:1995;253-259.
51. Norppa H., Hirvonen A., Järventaus H., Uusküla M., Tasa G., Ojajärvi A., Sorsa M. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes. Carcinogenesis. 16:1995;1261-1264.
52. Landi S., Ponzanelli I., Hirvonen A., Norppa H., Barale R. Repeated analysis of sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes: effect of glutathione S-transferase T1 and M1 genotype. Mutat. Res. 351:1996;79-85.
53. Landi S., Norppa H., Frenzilli G., Cipollini G., Ponzanelli I., Barale R., Hirvonen A. Individual sensitivity to cytogenetic effects of 1,2:3,4-diepoxybutane in cultured human lymphocytes: influence of glutathione S-transferase M1, P1 and T1 genotypes. Pharmacogenetics. 8:1998;461-471.
54. Pelin K., Hirvonen A., Norppa H. Influence of erythrocyte glutathione S-transferase T1 on sister chromatid exchanges induced by diepoxybutane in cultured human lymphocytes. Mutagenesis. 11:1996;213-215.
55. Vlachodimitropoulos D., Norppa H., Autio K., Catalán J., Hirvonen A., Tasa G., Uusküla M., Demopoulos N.A., Sorsa M. GSTT1-dependent induction of centromere-negative and -positive micronuclei by 1,2:3,4-diepoxybutane in cultured human lymphocytes. Mutagenesis. 12:1997;397-403.
56. Kligerman A.D., DeMarini D.M., Doerr C.L., Hanley N.M., Milholland V.S., Tennant A.H. Comparison of cytogenetic effects of 3,4-epoxy-1-butene and 1,2:3,4-diepoxybutane in mouse, rat and human lymphocytes following in vitro G0 exposures. Mutat. Res. 439:1999;13-23.
57. Hayes R.B., Zhang L., Yin S., Swenberg J.A., Xi L., Wiencke J., Bechtold W.E., Yao M., Rothman N., Haas R., O'Neill J.P., Zhang D., Wiemels J., Dosemeci M., Li G., Smith M.T. Genotoxic markers among butadiene polymer workers in China. Carcinogenesis. 21:2000;55-62.
58. Schlade-Bartusiak K., Sasiadek M., Kozlowska J. The influence of GSTM1 and GSTT1 genotypes on the induction of sister chromatid exchanges and chromosome aberrations by 1,2:3,4-diepoxybutane. Mutat. Res. 465:2000;69-75.
59. Porto B., Chiecchio L., Gaspar J., Faber A., Pinho L., Rueff J., Malheiro I. Role of haemoglobin in the protection of cultured lymphocytes against diepoxybutane (DEB), assessed by in vitro induced chromosome breakage. Mutat. Res. 536:2003;61-67.
60. Uusküla M., Järventaus H., Hirvonen A., Sorsa M., Norppa H. Influence of GSTM1 genotype on sister chromatid exchange induction by styrene-7,8-oxide and 1,2-epoxy-3-butene in cultured human lymphocytes. Carcinogenesis. 16:1995;947-950.
61. Bernardini S., Hirvonen A., Pelin K., Norppa H. Induction of sister chromatid exchange by 1,2-epoxy-3-butene in cultured human lymphocytes: influence of GSTT1 genotype. Carcinogenesis. 19:1998;377-380.
62. Sa̧siadek M., Hirvonen A., Noga L., Paprocka-Borowicz M., Norppa H. Glutathione S-transferase M1 genotype influences sister chromatid exchange induction but not adaptive response in human lymphocytes treated with 1,2-epoxy-3-butene. Mutat. Res. 439:1999;207-212.
63. Bernardini S., Pelin K., Peltonen K., Järventaus H., Hirvonen A., Neagu C., Sorsa M., Norppa H. Induction of sister chromatid exchange by 3,4-expoxybutane-1,2-diol in cultured human lymphocytes of different GSTT1 and GSTM1 genotypes. Mutat. Res. 361:1996;121-127.
64. Albertini R.J., Šrám R.J., Vacek P.M., Lynch J., Wright M., Nicklas J.A., Boogaard P.J., Henderson R.F., Swenberg J.A., Tates A.D., Ward J.B.J. Biomarkers of assessing occupational exposures to butadiene. Chem.-Biol. Interact. 135-136:2001;429-453.
65. Fustinoni S., Soleo L., Warholm M., Begemann P., Rannug A., Neumann H.G., Swenberg J.A., Vimercati L., Colombi A. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidemiol. Biomarkers Prev. 11:2002;1082-1090.
66. Begemann P., Šrám R.J., Neumann H.G. Hemoglobin adducts of epoxybutene in workers occupationally exposed to 1,3-butadiene. Arch. Toxicol. 74:2001;680-687.
67. Zhao C., Vodicka P., Šrám R.J., Hemminki K. DNA adducts of 1,3-butadiene in humans: relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points. Environ. Mol. Mutagen. 37:2001;226-230.
68. Sorsa M., Osterman-Golkar S., Peltonen K., Saarikoski S.T., Šrám R. Assessment of exposure to butadiene in the process industry. Toxicology. 113:1996;77-83.
69. M. Warholm, A. Rannug, S. Fustinoni, P. Begemann, L. Soleo, R. Barale, H. Järventaus, H. Norppa, Influence of metabolic genotypes on chromosome aberrations in butadiene exposed workers, in: Proceedings of the 42nd Annual Meeting of Society of Toxicology, March 9-13, 2003, Salt Lake City, 2003 (abstracts).
70. Šrám R.J., Rössner P., Peltonen K., Podrazilová K., Mrackova G., Demopoulos N.A., Stephanou G., Vlachodimitropoulos D., Darroudi F., Tates A.D. Chromosomal aberrations, sister-chromatid exchanges, cells with high frequency of SCE, micronuclei and comet assay parameters in 1,3-butadiene-exposed workers. Mutat. Res. 419:1998;145-154.
71. Kelsey K.T., Wiencke J.K., Ward J., Bechtold W., Fajen J. Sister-chromatid exchanges, glutathione S-transferase theta deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutat. Res. 335:1995;267-273.
72. Abdel-Rahman S.Z., Ammenheuser M.M., Ward J.B. Jr. Human sensitivity to 1,3-butadiene: role of microsomal epoxide hydrolase polymorphisms. Carcinogenesis. 22:2001;415-423.
73. Abdel-Rahman S.Z., El-Zein R.A., Ammenheuser M.M., Yang Z., Stock T.H., Morandi M., Ward J.B. Jr. Variability in human sensitivity to 1,3-butadiene: influence of the allelic variants of the microsomal epoxide hydrolase gene. Environ. Mol. Mutagen. 41:2003;140-146.
74. Bernardini S., Hirvonen A., Järventaus H., Norppa H. Influence of GSTM1 and GSTT1 genotypes on sister chromatid exchange induction by styrene in cultured human lymphocytes. Carcinogenesis. 23:2002;893-897.
75. Ollikainen T., Hirvonen A., Norppa H. Influence of GSTT1 genotype on sister chromatid exchange induction by styrene-7,8-oxide in cultured human lymphocytes. Environ. Mol. Mutagen. 31:1998;311-315.
76. Manini P., Buzio L., Andreoli R., Goldoni M., Bergamaschi E., Jakubowski M., Vodicka P., Hirvonen A., Mutti A. Assessment of biotransformation of the arene moiety of styrene in volunteers and occupationally exposed workers. Toxicol. Appl. Pharmacol. 189:2003;160-169.
77. Shield A.J., Sanderson B.J. Role of glutathione S-transferase mu (GSTM1) in styrene-7,8-oxide toxicity and mutagenicity. Environ. Mol. Mutagen. 37:2001;285-289.
78. Laffon B., Perez-Cadahia B., Pasaro E., Mendez J. Effect of epoxide hydrolase and glutathione S-tranferase genotypes on the induction of micronuclei and DNA damage by styrene-7,8-oxide in vitro. Mutat. Res. 536:2003;49-59.
79. Laffon B., Perez-Cadahia B., Pasaro E., Mendez J. Individual sensitivity to DNA damage induced by styrene in vitro: influence of cytochrome P450, epoxide hydrolase and glutathione S-transferase genotypes. Toxicology. 186:2003;131-141.
80. Buschini A., De Palma G., Poli P., Martino A., Rossi C., Mozzoni P., Scotti E., Buzio L., Bergamaschi E., Mutti A. Genetic polymorphism of drug-metabolizing enzymes and styrene-induced DNA damage. Environ. Mol. Mutagen. 41:2003;243-252.
81. Haufroid V., Buchet J.P., Gardinal S., Ghittori S., Imbriani M., Hirvonen A., Lison D. Importance of genetic polymorphisms of drug-metabolising enzymes for the interpretation of biomarkers of exposure to styrene. Biomarkers. 6:2001;236-249.
82. Haufroid V., Jakubowski M., Janasik B., Ligocka D., Buchet J.P., Bergamaschi E., Manini P., Mutti A., Ghittori S., Arand M., Hangen N., Oesch F., Hirvonen A., Lison D. Interest of genotyping and phenotyping of drug-metabolizing enzymes for the interpretation of biological monitoring of exposure to styrene. Pharmacogenetics. 12:2002;691-702.
83. De Palma G., Manini P., Mozzoni P., Andreoli R., Bergamaschi E., Cavazzini S., Franchini I., Mutti A. Polymorphism of xenobiotic-metabolizing enzymes and excretion of styrene-specific mercapturic acids. Chem. Res. Toxicol. 14:2001;1393-1400.
84. Manini P., De Palma G., Mozzoni P., Andreoli R., Poli D., Bergamaschi E., Franchini I., Mutti A. GSTM1 polymorphism and styrene metabolism: insights from an acute accidental exposure. Toxicol. Lett. 134:2002;201-208.
85. Vodicka P., Soucek P., Tates A.D., Dusinska M., Sarmanova J., Zamecnikova M., Vodickova L., Koskinen M., de Zwart F.A., Natarajan A.T., Hemminki K. Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat. Res. 482:2001;89-103.
86. Laffon B., Pasaro E., Mendez J. Evaluation of genotoxic effects in a group of workers exposed to low levels of styrene. Toxicology. 171:2002;175-186.
87. Hemminki K., Shields P.G. Skilled use of DNA polymorphisms as a tool for polygenic cancers. Carcinogenesis. 23:2002;379-380.